These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 1894013

  • 1. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM, Golan A, Weinraub Z, Bukovsky I, Caspi E.
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [Abstract] [Full Text] [Related]

  • 2. Antigestogens.
    Baird DT.
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [Abstract] [Full Text] [Related]

  • 3. Mifepristone (RU 486) for induced abortion.
    Grimes DA.
    Womens Health Issues; 1993 Jan; 3(3):171-5. PubMed ID: 8274873
    [Abstract] [Full Text] [Related]

  • 4. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

  • 5. Antiprogestin drugs: research and clinical use in Sweden.
    Bygdeman M, Swahn ML.
    Law Med Health Care; 1992 Feb; 20(3):157-60. PubMed ID: 1434756
    [Abstract] [Full Text] [Related]

  • 6. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume CJ, Baulieu EE.
    Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
    [Abstract] [Full Text] [Related]

  • 7. Mifepristone (RU486): a review.
    Mahajan DK, London SN.
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [Abstract] [Full Text] [Related]

  • 8. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE, Baulieu EE.
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [Abstract] [Full Text] [Related]

  • 9. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E.
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [Abstract] [Full Text] [Related]

  • 10. Anti-progesterones for the interruption of pregnancy.
    Bygdeman M, Van Look PF.
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265
    [Abstract] [Full Text] [Related]

  • 11. Progesterone antagonists on the horizon.
    Spitz IM, Bardin CW.
    Clin Obstet Gynecol; 1989 Jun; 32(2):403-13. PubMed ID: 2663280
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial on termination of early pregnancy with RU486 in combination with prostaglandin.
    Wu S, Gao J, Wu Y, Wu M, Fan H, Yao G, Zheng S, Wang P, Du M, Huang Z.
    Contraception; 1992 Sep; 46(3):203-10. PubMed ID: 1451516
    [Abstract] [Full Text] [Related]

  • 13. Mifepristone: a potential contraceptive.
    Heikinheimo O, Archer DF.
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandins and progesterone receptor antagonists in human fertility regulation.
    Healy DL.
    Aust N Z J Obstet Gynaecol; 1994 Jun; 34(3):357-60. PubMed ID: 7848216
    [Abstract] [Full Text] [Related]

  • 15. Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.
    Healy DL.
    Reprod Fertil Dev; 1990 Jun; 2(5):477-90. PubMed ID: 1963697
    [Abstract] [Full Text] [Related]

  • 16. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML, Ugocsai G, Bygdeman M, Kovacs L, Belsey EM, Van Look PF.
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [Abstract] [Full Text] [Related]

  • 17. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW, Baird DT.
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [Abstract] [Full Text] [Related]

  • 18. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
    Nayak NR, Sengupta J, Ghosh D.
    Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
    [Abstract] [Full Text] [Related]

  • 19. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C, Olund A.
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [Abstract] [Full Text] [Related]

  • 20. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Thong KJ, Lynch P, Baird DT.
    Contraception; 1996 Aug; 54(2):97-100. PubMed ID: 8842586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.